81 – 90 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden
(
- Contribution to journal › Article
- 2008
-
Mark
Germline Genes Specific to Chronic Lymphocytic Leukemia (CLL) and Genes Common to CLL, Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia, and Other Non-Hodgkin Lymphomas Are Important in Susceptibility
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased risk of monoclonal gammopathy of undetermined significance (MGUS) and lymphoid tumors among first-degree relatives of MGUS cases
2008) 17th Annual Meeting of the International-Genetic-Epidemiology-Society In Genetic Epidemiology 32(7). p.691-691(
- Contribution to journal › Published meeting abstract
-
Mark
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden
(
- Contribution to journal › Article
-
Mark
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
(
- Contribution to journal › Article
-
Mark
Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Immune-Related and Inflammatory Conditions Likely Play a Role in the Development of Lymphoplasmacytic Lymphoma/Waidenstrom's Macroglobulinemia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
(
- Contribution to journal › Article
-
Mark
Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.166-166(
- Contribution to journal › Published meeting abstract
-
Mark
A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0209-0209(
- Contribution to journal › Published meeting abstract